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A method of cell culture termed organoid culture has been developed to expand tissue stem cells 
from various organs. In the recent Cell article, Huch, Gehart et al. applied organoid culture to cells 
derived from human liver, including from standard biopsies, to expand liver epithelial cells.
1
 Cells 
grown as organoids could be massively expanded, remained genetically and phenotypically stable 
and could be differentiated into hepatocyte like cells. Cells expanded from patients with genetic liver 
diseases expressed the disease phenotype following differentiation. Organoid expansion was only 
successful using EpCAM positive biliary ductular cells rather than mature hepatocytes.  
 
Primary human hepatocytes are used therapeutically for transplantation due to their synthetic and 
metabolic capacity. Hepatocytes also have potential for therapeutic use in “bioartificial livers” and are 
important cells to the pharma sector for drug testing. However, fresh human hepatocytes have been 
challenging to work with as they do not expand significantly ex-vivo in conventional monolayer culture 
and rapidly de-differentiate. This has fuelled the search for a culture-expandable human hepatocyte, 
either by devising culture techniques to allow primary hepatocytes to expand in vitro, or by identifying 
a clonogenic liver stem cell that could be expanded significantly in vitro without undergoing genetic 
mutations, yet retaining the ability to differentiate into hepatocytes when supplied with appropriate 
differentiation signals. In the absence of the former there has been increasing focus on the 
development of hepatocyte-like cells from human pluripotent stem cells such as embryonic stem cell 
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(ESC) or induced pluripotent stem cell (iPSC) derived hepatocytes.
2,3
 However recent studies have 
raised concerns regarding the phenotypic maturity of these cells,
4
 another lingering concern is their 
phenotypic and genetic stability and, consequently, their safety in vivo. This publication is therefore 
timely.  
Leading up to this work has been an impressive series of observations in the field of adult stem cells. 
Lgr5 is a cell marker that has been used to great effect to identify adult cells with stem cell like 
properties, initially in mouse gut but later in a variety of tissues. An important aspect that developed 
out of this work was the use of the organoid culture technique whereby stem cells could be expanded 
under the influence of Wnt signalling, whilst keeping some of their 3 dimensional cell-cell interactions.
4
 
This was first developed in the growth of gut organoids but was later applied to mouse liver where 
liver organoids could be grown from Lgr5+ epithelial cells isolated from adult mouse liver, and 
following expansion the cells could be differentiated into hepatocytes.
6
  
Huch, Gehart et al. report in the journal Cell that the organoid cell culture technique was successfully 
utilised to expand primary untransformed epithelial cells from adult human liver (see figure).
1
 This 
seminal study was able to show massive expansion of the epithelial cells in organoids. Of note the 
authors identified several key factors that enables the expansion of the organoids including the need 
for Wnt signalling, the addition of cAMP agonists and the inhibition of TGFbeta signalling. 
Critically, for disease modelling and possible therapeutic use, the expanding epithelial cells were 
genetically stable and few base pair substitutions in protein coding regions were identified during the 
expansion phase of the organoids. Given the high degree of clonogenicity of the organoids, significant 
cell numbers can be expanded from small numbers of starting cells and this includes standard liver 
biopsies- opening the door for many diagnostic research and potentially therapeutic possibilities. 
Given that the expanded cells retained their ability to be differentiated into mature hepatocytes, one 
can envisage possible clinical cell therapy using the organoid expansion technique. Using 
“differentiation conditions” the expanding progenitor cells were differentiated into hepatocytes that had 
synthetic and drug metabolising capacity in vitro. When 1–2 × 10
6
 human liver organoid cells from 4 
donors were injected intrasplenically into 5 immunodeficient mice with liver injury they engrafted the 
liver at low levels in 2 of the 5 recipients. At 120 days post-transplant, donor cells were mostly seen 
as single cells or doublets, but occasionally as small cells clusters. These mice had very low, but 
detectable levels of human albumin in their blood. The sub-therapeutic albumin levels are likely due to 
the very low engraftment levels and their future use in models with a selective advantage for the 
transplanted cells would be interesting.   
An important question is what would be the best mode of therapeutic application? This could 
potentially range from ex vivo use in a bioartificial liver to direct cell therapy. For cell therapy, in 
addition to significantly increasing cell engraftment, it would be important to ascertain whether the 
organoid derived hepatocytes form functional connections with other liver cells. Retention of 
homeostatic qualities is also vital, i.e. do the cells divide appropriately following injury but remain 
quiescent at other times. Furthermore are the cells phenotypically stable following injury in vivo?  
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Obviously for autologous therapy of genetic liver diseases of the hepatocyte some form of gene 
correction ex-vivo would be required. This has been previously tested using iPSCs derived 
hepatocytes derived from patients with alpha-1-antitrypsin (A1AT) deficiency.
7
  
Another positive finding is that the differentiated hepatocytes recapitulated the disease phenotypes 
which may facilitate “disease in the dish” modelling and drug testing. The authors grew organoids 
from liver biopsies of patients with A1AT deficiency and upon differentiation the hepatocytes exhibited 
the disease phenotype with an accumulation of the mutant A1AT in hepatocytes and lack of functional 
A1AT secretion. The disease modelling was not limited to hepatocytes. When a single biopsy from 
one Alagille syndrome patient was tested, the authors could grow organoids but when a biliary 
differentiation protocol was applied the differentiating cells failed to form luminal structures and the 
cells underwent apoptosis. Alagille syndrome is caused by mutations in the Notch-signaling pathway 
leading to biliary atresia and it would be interesting to know whether such a phenotype could be 
corrected in vitro. Whilst this was only a single sample, it does indicate the potential of organoids for 
disease modelling of biliary diseases. 
Only EpCAM positive ductal cells could serve as expendable cells in the organoids growth system 
whereas mature EpCAM negative hepatocytes could not be expanded. This is in interesting direct 
contrast to recent in vivo mouse lineage tracing reports, which could not identify ductal cells or hepatic 
progenitor cells with hepatocyte regeneration potential, and suggested all hepatocyte regeneration 
occurred through hepatocyte self-duplication.
8
 Whilst the studies are entirely different and cannot be 
directly compared, it does raise the question as to why hepatocytes self-replicate so readily in vivo 
and ductular cells do not robustly regenerate hepatocytes in published mouse models. This may be 
due to several theoretical reasons: (1) Mouse hepatocytes and ductular cells may be different in their 
proliferation and differentiation potential to human cells, (2) In vitro organoid expansion conditions are 
not recapitulated in vivo and although useful are “artificial” and do not inform the in vivo situation in 
mouse and human liver, or (3) The published mouse models of liver injury and regeneration do not 
accurately model the severe liver injury seen in human disease where there is often significant 
hepatocyte senescence and a major ductular response. Answering these questions will help us 
understand the regenerative potential of liver’s different cellular compartments, why regeneration fails 
in disease and how best to remedy this.   
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Figure legend 
Human liver cell expansion using the organoid culture system. 
Liver tissue was perfused and epithelial cells were separated into ductal cells and hepatocytes before 
plating in organoid culture medium. EpCAM+ ductal cells were readily and massively expandable as 
organoids, whereas EpCAM- hepatocytes could not be expanded. The EpCAM+ ductal cells 
maintained a high degree of genetic stability during the expansion, were bipotential and could be 
differentiated into cells with a hepatocyte or biliary cell phenotype and function. Organoids grown from 
the livers of patients with genetic biliary diseases expressed the disease phenotype upon 
differentiation. Cells grown as organoids could be transplanted into immunodeficient mice but had a 
low engraftment level in the Retrorsine/CCl4 model used and consequently produced low levels of 
human serum albumin. (reprinted under Creative Commons license) 
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